Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Bruker Corporation (Nasdaq: BRKR) will present at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023, at 10:30 AM EST in San Francisco. Key executives, including Chairman Frank Laukien and CFO Gerald Herman, will represent the company. A live audio webcast of the presentation can be accessed via the Investor Relations section of Bruker's website, with a replay available for 30 days thereafter. Bruker specializes in high-performance scientific instruments that support significant advancements in life sciences and material sciences.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 41^st annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 9^th, 2023 at 10:30 AM Eastern Standard Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221221005583/en/

Investors:

Justin Ward

Senior Director, Investor Relations & Corporate Development

+1 (978) 663-3660 x1479

Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

When is Bruker Corporation's presentation at the J.P. Morgan Healthcare Conference?

Bruker Corporation's presentation is scheduled for January 9, 2023, at 10:30 AM Eastern Standard Time.

Who will represent Bruker Corporation at the J.P. Morgan Healthcare Conference?

Key executives including Frank Laukien, Mark Munch, and Gerald Herman will represent Bruker Corporation.

How can I access Bruker Corporation's presentation at the J.P. Morgan Healthcare Conference?

The presentation will be available via a live audio webcast on Bruker's Investor Relations website.

Will there be a replay of Bruker Corporation's presentation available?

Yes, a replay of the presentation will be posted for 30 days on the 'Events & Presentations' section of Bruker's Investor Relations site.

What is Bruker Corporation's focus in the scientific field?

Bruker Corporation specializes in high-performance scientific instruments and analytical solutions for life sciences, material sciences, and industrial applications.